Using machine learning approaches to predict response to neoadjuvant chemotherapy in patients with triple-negative breast cancer

被引：0
|
作者：
Fisher, Timothy Byron
Li, Hongxiao
Ts, Rekha
Krishnamurthy, Jayashree
Bhattarai, Shristi
Janssen, Emiel A. M.
Kong, Jun
Aneja, Ritu
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P1-08-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-08-16
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect of tumor microenvironment on chemotherapy response of patients with triple-negative breast cancer receiving neoadjuvant chemotherapy
    Kim, Jae-Joon
    Kim, Dongjin
    Yu, Yeuni
    Jung, Ki Sun
    Kim, Yun Hak
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    Jung, Yoon Yang
    Hyun, Chang Lim
    Jin, Min-Sun
    Park, In Ae
    Chung, Yul Ri
    Shim, Bobae
    Lee, Kyu Ho
    Ryu, Han Suk
    JOURNAL OF BREAST CANCER, 2016, 19 (03) : 261 - 267
  • [23] Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple-negative breast cancer (TNBC).
    Krivorotko, Petr
    Zhiltsova, Elena
    Gigolaeva, Larisa
    Emelyanov, Alexander
    Pesotskiy, Roman
    Yerechshenko, Sergey
    Nikolaev, Kirill
    Komyahov, Alexander
    Ivanova, Olga
    Tabagua, Tengiz
    Zernov, Konstantin
    Ivanov, Vadim
    Aseeva, Zalina
    Bessonov, Alexander
    Semiglazov, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Pretreatment Sarcopenia and MRI-Based Radiomics to Predict the Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    Guo, Jiamin
    Meng, Wenjun
    Li, Qian
    Zheng, Yichen
    Yin, Hongkun
    Liu, Ying
    Zhao, Shuang
    Ma, Ji
    BIOENGINEERING-BASEL, 2024, 11 (07):
  • [25] Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    Irajizad, Ehsan
    Wu, Ranran
    Vykoukal, Jody
    Murage, Eunice
    Spencer, Rachelle
    Dennison, Jennifer B.
    Moulder, Stacy
    Ravenberg, Elizabeth
    Lim, Bora
    Litton, Jennifer
    Tripathym, Debu
    Valero, Vicente
    Damodaran, Senthil
    Rauch, Gaiane M.
    Adrada, Beatriz
    Candelaria, Rosalind
    White, Jason B.
    Brewster, Abenaa
    Arun, Banu
    Long, James P. P.
    Do, Kim Anh
    Hanash, Sam
    Fahrmann, Johannes F.
    FRONTIERS IN ARTIFICIAL INTELLIGENCE, 2022, 5
  • [26] BRCAness and prognosis in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Sengoku, Norihiko
    Waraya, Mina
    Nishimiya, Hiroshi
    Katoh, Hirozhi
    Kikuchi, Mariko
    Minatani, Naoko
    Teraoka, Saeko
    Enomoto, Takumo
    Sato, Takeo
    Masahiko, Masahiko
    CANCER RESEARCH, 2015, 75
  • [27] BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Nishimiya, Hiroshi
    Tanaka, Youko
    Minatani, Naoko
    Kikuchi, Mariko
    Shida, Akiko
    Waraya, Mina
    Katoh, Hiroshi
    Enomoto, Takumo
    Sengoku, Norihiko
    Kajita, Sabine
    Hoffman, Robert M.
    Watanabe, Masahiko
    PLOS ONE, 2016, 11 (12):
  • [28] Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer
    Stover, Daniel G.
    Bell, Caitlin F.
    Tolaney, Sara M.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 6 - 12
  • [29] Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy
    Marra, Antonio
    Curigliano, Giuseppe
    CANCER JOURNAL, 2021, 27 (01): : 41 - 49
  • [30] Response to Neoadjuvant Chemotherapy of Triple Negative Breast Cancer
    Tokudome, N.
    Ito, Y.
    Takahashi, S.
    Sugihara, T.
    Hosonaga, M.
    Iwasaki, R.
    Hattori, M.
    Fukuda, T.
    Mitsuhashi, K.
    Kobayashi, K.
    Taira, S.
    Saito, Y.
    Fukada, I
    Ueki, N.
    Tsutsumi, C.
    Miyagi, Y.
    Iwase, T.
    Osako, T.
    Horii, R.
    Akiyama, F.
    Hatake, K.
    CANCER RESEARCH, 2009, 69 (24) : 571S - 572S
12345